Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Treatment of Opioid Use Disorder During Pregnancy May Increase Cases of Neonatal Abstinence Syndrome—Reply

Treatment of Opioid Use Disorder During Pregnancy May Increase Cases of Neonatal Abstinence... Letters Author Contributions: Dr J. McDonald had full access to all of the data in the to identify whether infants were exposed in utero to opioid study and takes responsibility for the integrity of the data and the accuracy of treatment or to illicit opioids. Methadone and buprenor- the data analysis. phine reduce cravings and decrease the stressful cycle of with- Concept and design: J. McDonald, R. McDonald, Jentoft, Kallmes, Eckel. drawal and intoxication for the mother and fetus. Because of Acquisition, analysis, or interpretation of data: J. McDonald, R. McDonald, Jentoft, Paolini, Murray. this, treatment of pregnant women with opioid use disorder Drafting of the manuscript: J. McDonald, R. McDonald, Eckel. with opioid agonist therapy has shown to have improved ma- Critical revision of the manuscript for important intellectual content: All authors. ternal outcomes (eg, reduction in overdose risk and reduc- Statistical analysis: J. McDonald, R. McDonald. Administrative, technical, or material support: R. McDonald, Jentoft, Paolini, tion in relapse risk) and infant outcomes (eg, higher birth 3,4 Eckel. weights and longer gestation). The American College of Ob- Supervision: Kallmes. stetrics and Gynecology and the American Academy of Pedi- Conflict of Interest Disclosures: Drs J. McDonald and Kallmes report http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Pediatrics American Medical Association

Treatment of Opioid Use Disorder During Pregnancy May Increase Cases of Neonatal Abstinence Syndrome—Reply

JAMA Pediatrics , Volume 171 (7) – Jul 1, 2017

Loading next page...
 
/lp/american-medical-association/treatment-of-opioid-use-disorder-during-pregnancy-may-increase-cases-DsRuWDUdE0

References (3)

Publisher
American Medical Association
Copyright
Copyright 2017 American Medical Association. All Rights Reserved.
ISSN
2168-6203
eISSN
2168-6211
DOI
10.1001/jamapediatrics.2017.0863
Publisher site
See Article on Publisher Site

Abstract

Letters Author Contributions: Dr J. McDonald had full access to all of the data in the to identify whether infants were exposed in utero to opioid study and takes responsibility for the integrity of the data and the accuracy of treatment or to illicit opioids. Methadone and buprenor- the data analysis. phine reduce cravings and decrease the stressful cycle of with- Concept and design: J. McDonald, R. McDonald, Jentoft, Kallmes, Eckel. drawal and intoxication for the mother and fetus. Because of Acquisition, analysis, or interpretation of data: J. McDonald, R. McDonald, Jentoft, Paolini, Murray. this, treatment of pregnant women with opioid use disorder Drafting of the manuscript: J. McDonald, R. McDonald, Eckel. with opioid agonist therapy has shown to have improved ma- Critical revision of the manuscript for important intellectual content: All authors. ternal outcomes (eg, reduction in overdose risk and reduc- Statistical analysis: J. McDonald, R. McDonald. Administrative, technical, or material support: R. McDonald, Jentoft, Paolini, tion in relapse risk) and infant outcomes (eg, higher birth 3,4 Eckel. weights and longer gestation). The American College of Ob- Supervision: Kallmes. stetrics and Gynecology and the American Academy of Pedi- Conflict of Interest Disclosures: Drs J. McDonald and Kallmes report

Journal

JAMA PediatricsAmerican Medical Association

Published: Jul 1, 2017

There are no references for this article.